학술논문
Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes
Document Type
Article
Author
Source
In Annals of Oncology July 2016 27(7):1317-1323
Subject
Language
ISSN
0923-7534